Navigation Links
Mechanism for the in-vivo transport of siRNA
Date:9/17/2007

le of being bonded to other lipophilic substances in addition to cholesterol, and caused a reduction in the activity of a target gene in the liver at the same time. It turned out that there are several such fatty acids. But what is it in the blood to which all these RNAs conjugated with so-called lipophilic substances bond" The ETH Zurich researchers discovered that, depending on the fatty acid used, the binding partners are the well-known cholesterol transporters High Density Lipoproteins (HDL) and Low Density Lipoproteins (LDL) as well as the albumin (protein) present everywhere in the blood. Without these lipoprotein particles there is no uptake of siRNAs into the tissues, as became apparent from further experiments. In an additional experiment the scientists demonstrated that the uptake can be made considerably more efficient if the siRNA-fatty acid molecules are already firmly bonded to HDL and LDL before being administered. Stoffels team also discovered that there is preferential uptake into different tissues depending on whether an siRNA-fatty acid molecule is bonded to HDL or LDL: all LDL compounds trigger responses in the liver, but HDL compounds also do so in the intestine or kidneys.

An irritating finding

The latter finding indicated that the uptake proceeds via HDL and LDL receptors. The researchers proved this assumption by inactivating the receptors, with the result that uptake no longer occurred. Despite the clarity of the finding, it irritated Stoffel slightly. He found it hard to imagine that the siRNAs were able to enter the cell via the normal absorption route like HDL, because this route leads into the cells own digestive system with lysosomes that would degrade the siRNAs. So how would the siRNAs be able to avoid this degradation" Stoffel concluded that they simply use a different doorway into the cell. Thus the HDL and LDL receptors would only act as docking stations but not as an entry portal.

But what might t
'/>"/>

Contact: Professor Marcus Stoffel
41-446-334-560
Swiss Federal Institute of Technology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. A new mechanism of regulating RNA degradation
2. Plants, animals share molecular growth mechanisms
3. PET/MRI scans may help unravel mechanisms of prenatal drug damage
4. Researchers discover molecular mechanism that desensitizes us to cold
5. Chemists identify immune system mechanism for methamphetamine binges
6. Key mechanism in genetic inheritance during cell division identified
7. Researchers unlock mechanism creating jigsaw puzzle-like plant cells
8. Mouse gene shows new mechanism behind cardiac infarction in man
9. UCSD research reveals mechanism involved with type of fatal epilepsy
10. Ancient immune defense mechanism is no match for HIV-1
11. Malaria mechanism revealed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/11/2010)... 11, 2010) Van Andel Research Institute (VARI) ... cells that line and protect the prostate in relation to ... that normal cells and cancer cells depend on different factors ... cancer cells without affecting normal cells when developing treatments. , ... men, with more than 192,000 new cases and more than ...
(Date:3/11/2010)... have been able to confine and study an individual ... without having to pin it down so tightly as ... practical application to proteins of a recently developed technique, ... of the dynamic behavior of the molecule for more ... viewing time compared to other methods, and thereby "set ...
(Date:3/11/2010)... collective efforts to develop new drugs, the pharmaceuticals ... on the application of natural biological transformation processes. ... cultivation of microorganisms or cells in a bioreactor ... manufacture is subject to especially strict regulations, the ... precisely. Possibilities for analysis inside the reactor itself ...
Breaking Biology News(10 mins):VAI researchers develop tool to help study prostate cancer 2Behavior of single protein observed in unprecedented detail by Stanford chemists 2Behavior of single protein observed in unprecedented detail by Stanford chemists 3Clean sampling from bioreactors 2RadMD Reaches 150th Clinical Trial 5213 1RadMD Reaches 150th Clinical Trial 5213 2RadMD Reaches 150th Clinical Trial 5213 3IncentOne Introduces Next Generation of Healthy Choice Award 28TM 29 Incentive Solution to Drive Consumer and Provider Engagement 5209 1IncentOne Introduces Next Generation of Healthy Choice Award 28TM 29 Incentive Solution to Drive Consumer and Provider Engagement 5209 2Intensive care units poorly equipped to care for the dying 58854 1Intensive care units poorly equipped to care for the dying 58854 2
... many of the same health problems as tobacco smoke, such ... to a new study by researchers at Yale School of ... drug in the United States, and abuse of the drug ... Archives of Internal Medicine. First author Jeanette M. Tetrault, M.D., ...
... diabetes (DT2) has been elucidated, for the first time, ... allowing 400,000 DNA mutations to be studied simultaneously. New ... They include the zinc transporter of pancreatic insulin-secreting cells ... study of the French population was carried out as ...
... The new findings, which are being published the week ... Proceedings of the National Academy of Sciences, offer significant ... that lead to abnormal amyloid fibril conversion. The new ... targets for neurodegenerative diseases. , Intriguingly, certain prions and ...
Other Biology News:Long-term marijuana smoking leads to respiratory complaints 2Elucidation of the genome for diabetics with DNA chips 2Elucidation of the genome for diabetics with DNA chips 3Scripps research study reveals structural dynamics of single prion molecules 2Scripps research study reveals structural dynamics of single prion molecules 3
(Date:3/11/2010)... at Philadelphia Conference , ... Chicago, ... of Clinical Trial Operations (CTO) software, today announced it will ... Bank and Cowen & Company at CBI,s 2010 Accounting and ... attended each year by over 300 finance, accounting, audit and ...
(Date:3/11/2010)... and SEATTLE, Washington , March 11, 2010 , ProFibrix B.V., ... announced the,conclusion of the first Phase II trial testing its unique new hemostat,Fibrocaps(TM). ... (time to hemostasis),profiles for Fibrocaps, and good performance of the delivery device. , ... ... ...
(Date:3/10/2010)... Complete Genomics Inc., a third-generation human genome ... Systems Biology (ISB) employed Complete Genomics, human genome ... determine the depth of genetic information possible in ... the gene responsible for Miller syndrome, a rare ... online later today in the journal Science ...
(Date:3/10/2010)... , ... ... ... , ... ...
Breaking Biology Technology:ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 2ClearTrial to Head Panel of Leading Wall Street Analysts at Pharmaceutical Accounting and Reporting Congress 3ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer 2ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer 3Institute for Systems Biology uses Complete Genomics' genome sequencing service to verify gene responsible for Miller syndrome 2Toxikon Corporation Hosts Extractables and Leachables Spring Seminar 2Toxikon Corporation Hosts Extractables and Leachables Spring Seminar 3
... 8, Features ... Companies Renowned Investment Banker and Biotechnology Company Start-up ... Stelios Papadopoulos, PhD Provides Keynote Address, ... MASS Opportunities Investor Conference, New,England,s largest biotechnology investor forum, ...
... Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) today ... presentations at the AACR-NCI-EORTC,International Conference on Molecular Targets ... They will highlight drug discovery,efforts focused on significant ... like kinase 1 (PLK1) and Janus tyrosine kinase,2 ...
... of the ,200 Best Small Companies In America, ... ABAX ), a medical products company manufacturing point-of-care,blood chemistry ... chief executive officer, was named "Entrepreneur of,the Year" by ... in that,issue, Abaxis was ranked eleventh of the "200 ...
Other Biology Technology:2007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies 22007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies 3Rigel to Present Research Programs at Scientific Conferences 2Rigel to Present Research Programs at Scientific Conferences 3Abaxis CEO Clint Severson Named 'Entrepreneur of the Year' by Forbes Magazine 2
Pim-1 (12H8)...
Ets-1...
Mouse monoclonal [3G131] to Desmoglein 1 ( Abpromise for all tested applications). entrezGeneID: 1828 SwissProtID: Q02413...
Rat Antibody to Mouse TCR VB8.1,8.2:FITC Recognises the V beta 8.1 and V beta 8.2 determinants of the murine T cell receptor. Specificity: mouse TCR VB8.1 and 8.2...
Biology Products: